Grant Writing Workshop: Non-dilutive grant funding for early-stage technology companies

Attend for an overview of SBIR/STTR programs relating to biomedical and medical device technologies with a focus on NIH and NSF.

About this event:

Attend to hear Natalie Rudolph go over the following topics:

• Overview of SBIR/STTR programs relating to biomedical and medical device technologies,
with a focus on NIH and NSF

• Essential elements of a successful SBIR/STTR project

• Key components of a competitive SBIR/STTR application

Natalie will also be hosting 1:1 meetings from 1pm – 3pm for those who are interested in connecting with her further. If you’re interested in scheduling time with her please send us an email at M2D2@uml.edu.

Natalie S. Rudolph, Ph.D.

Rudolph Biomedical Consulting

Rudolph Biomedical Consulting works with early-stage technology companies to identify potential non-dilutive funding sources, design R&D projects, and write grant applications to fund them. Project areas include biotechnology, medical devices and telehealth. My focus is Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) grants and contracts from NIH, NSF and DOD. However, my work spans a wide range of opportunities from agencies such as BARDA, DARPA, NIH, NSF, DoD, AHRQ and PCORI. My clients include small companies and academic investigators, and institutions preparing large complex program proposals.

My projects begin with a planning exercise to define the goals and deliverables and to outline the proposed work. This allows us to determine the best match with the funding opportunity objectives, scope, budget and duration.

I love working with the energy and enthusiasm of entrepreneurs!